Company Presentation

Engimmune Therapeutics is a world-class developer of highly targeted, highly potent ‘off-the-shelf’ soluble T-cell receptor drugs (TCRs) to treat solid tumour cancers. Its cutting-edge proprietary platform technologies enable it to rapidly identify and engineer stable, soluble, multi-specific TCR cell engager that have extremely high affinity for target to enable efficient tumour infiltration and long on-tumour half-life. Our lead program is targeting clinical entry early 26